P

Active Director Director DIN 08597297
DIN 08597297 First appointment Oct 2019 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2019
Shareholding value •••• Premium profile

About Pandey

Data last updated:

Pandey is a Director at Armn Pharmaceutical India Private Limited (since 2019). The company operates in Pharma. Armn Pharmaceutical India Private Limited reported revenue of ₹40.1 Lakh (FY 2023).

DIN 08597297
Primary Designation Director
Industry Pharma
First Appointment 25 Oct 2019
Oldest Company Age 7 yrs
Largest company Armn Pharmaceutical India Private Limited · ₹40.1 Lakh (FY 2023)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director25 Oct 20192019₹40.1 Lakh (FY 2023)Active

Directorship timeline

Open interactive timeline →
Armn Pharmaceutical India Private Limited
Premium access

Shareholding and investment profile for Pandey

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Pandey

Pandey currently holds 1 directorship: Armn Pharmaceutical India Private Limited (Director, since 25 Oct 2019, revenue ₹40.1 Lakh (FY 2023)).

Pandey was first appointed on 25 Oct 2019 as Director at Armn Pharmaceutical India Private Limited.

The current boards of Pandey's companies include Karamvir Singh Malik (Armn Pharmaceutical India Private Limited), Monika (Armn Pharmaceutical India Private Limited), Poonam Tewatia (Armn Pharmaceutical India Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available